<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5297774</article-id><article-id pub-id-type="doi">10.3390/ijms18010141</article-id><article-id pub-id-type="publisher-id">ijms-18-00141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Multiple Activities of <italic>Punica granatum</italic> Linne against Acne Vulgaris</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Chia-Jung</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00141">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Lih-Geeng</given-names></name><xref ref-type="aff" rid="af2-ijms-18-00141">2</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Wen-Li</given-names></name><xref ref-type="aff" rid="af3-ijms-18-00141">3</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ching-Chiung</given-names></name><xref ref-type="aff" rid="af1-ijms-18-00141">1</xref><xref ref-type="aff" rid="af3-ijms-18-00141">3</xref><xref ref-type="aff" rid="af4-ijms-18-00141">4</xref><xref rid="c1-ijms-18-00141" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Andrade</surname><given-names>Paula</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Valent&#x000e3;o</surname><given-names>Patr&#x000ed;cia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-18-00141"><label>1</label>PhD Program for Clinical Drug Discovery of Chinese Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan; <email>cjlee@tmu.edu.tw</email></aff><aff id="af2-ijms-18-00141"><label>2</label>Department of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences, National Chiayi University, Chiayi 60004, Taiwan; <email>lgchen@mail.ncyu.edu.tw</email></aff><aff id="af3-ijms-18-00141"><label>3</label>School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan; <email>wenlee@tmu.edu.tw</email></aff><aff id="af4-ijms-18-00141"><label>4</label>Orthopedics Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan</aff><author-notes><corresp id="c1-ijms-18-00141"><label>*</label>Correspondence: <email>crystal@tmu.edu.tw</email>; Tel.: +886-2-2736-1661 (ext. 6161)</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2017</year></pub-date><volume>18</volume><issue>1</issue><elocation-id>141</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2017 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2017</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Acne is a common skin condition with sebum overproduction, hyperkeratosis, <italic>Propionibacterium acnes</italic> (<italic>P</italic>. <italic>acnes</italic>) and <italic>Staphylococcus aureus</italic>, and inflammation. <italic>Punica granatum</italic> (pomegranate) is well-known for its anti-inflammatory effects; however, few studies have discussed the anti-acne effects of pomegranate. In this study, we found that pomegranate extract (PG-E) significantly reduced <italic>P</italic>. <italic>acnes</italic>-induced edema in Wistar rat ears. Therefore, an evaluation platform using multiple pathogenic mechanisms of acne was established to explore the anti-acne effects of pomegranate. Results showed that PG-E inhibited bacterial growth and lipase activity. Through a bioguided-fractionation-isolation system, four hydrolysable tannins, punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>), were isolated. Compounds <bold>1</bold> and <bold>2</bold> had greater anti-bacterial activities and anti-testosterone-induced HaCaT proliferative effects than the others. Compounds <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> displayed lipase inhibitory effects. Compound <bold>4</bold> decreased cyclooxygenase-2 expression and downregulated prostaglandin E<sub>2</sub> production in heat-killed <italic>P</italic>. <italic>acnes</italic>-treated RAW 246.7 cells. In conclusion, PG-E is abundant in hydrolysable tannins that display multiple anti-acne capacities, including anti-bacterial, anti-lipase, anti-keratinocyte proliferation, and anti-inflammatory actions. Hence, PG-E has great potential in the application of anti-acne and skin-care products, and punicalagin (<bold>1</bold>), the most effective component in PG-E, can be employed as a quality control marker.</p></abstract><kwd-group><kwd>acne</kwd><kwd><italic>Punica</italic><italic>granatum</italic></kwd><kwd>anti-inflammation</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-18-00141"><title>1. Introduction</title><p>Acne vulgaris (acne), a common skin disease, usually appears in young adolescents with a hormone imbalance [<xref rid="B1-ijms-18-00141" ref-type="bibr">1</xref>,<xref rid="B2-ijms-18-00141" ref-type="bibr">2</xref>]. More than 85% of teenagers are affected by acne, and most of them continue to be affected into adulthood. In the United States, acne therapies cost approximately $1 billion per year, while more than $100 million is spent on over-the-counter acne products [<xref rid="B3-ijms-18-00141" ref-type="bibr">3</xref>,<xref rid="B4-ijms-18-00141" ref-type="bibr">4</xref>]. Major causes of acne formation are fourfold: (1) increasing sebum production by overactive oil glands; (2) retention hyperkeratosis, which blocks skin pores; (3) activities of normal skin bacteria (<italic>Propionibacterium acnes</italic> and <italic>Staphylococcus aureus</italic>); and (4) skin inflammation [<xref rid="B5-ijms-18-00141" ref-type="bibr">5</xref>].</p><p>In sebum production, human sebum is composed of fatty acids, triglycerides, wax esters, and so on. Skin areas rich in sebaceous glands are positively correlated with acne lesions [<xref rid="B2-ijms-18-00141" ref-type="bibr">2</xref>]. Nowadays, one therapeutic strategy for the increased sebum production is topical use of azelaic acid, a dicarboxylic acid found in rye, wheat, and barley, which can block the synthesis of fatty acids to avoid the overproduction of sebum. However, long-term use of azelaic acid results in skin depigmentation [<xref rid="B6-ijms-18-00141" ref-type="bibr">6</xref>]. Evidences have shown that <italic>Chamaecyparis obtuse</italic> (<italic>C</italic>. <italic>obtuse</italic>) extract and tea tree oil were usually applied for the reduction of sebum productions. However, the therapeutic effect of <italic>C</italic>. <italic>obtuse</italic> is suboptimal and toxicity issue should be concerned in the use of tea tree oils [<xref rid="B7-ijms-18-00141" ref-type="bibr">7</xref>]. In hyperkeratosis, androgens, such as testosterone, cause hyperresponsiveness that stimulates sebocytes and follicular keratinocytes, resulting in hyperplasia of the sebaceous glands [<xref rid="B1-ijms-18-00141" ref-type="bibr">1</xref>]. <italic>Artemisia capillaries</italic> (<italic>A</italic>. <italic>capillaries</italic>) is reported for its anti-inflammatory effects against hepatic injury. Topical application of <italic>A</italic>. <italic>capillaries</italic> reduced hyperkeratosis of the epidermis, also suggesting the potential therapeutic activity to treat atopic dermatitis [<xref rid="B8-ijms-18-00141" ref-type="bibr">8</xref>]. Retinoic acid and salicylic acid are typically use to treat hyperkeratinization, but these chemical agents also lead to skin irritation and desquamation [<xref rid="B9-ijms-18-00141" ref-type="bibr">9</xref>]. In skin bacterial infections, oral anti-biotics such as tetracycline, erythromycin, and clindamycin are the most popular drugs for treating bacteria-induced acne at present. Overuse of antibiotics is a huge problem for modern medicine, because it results in anti-biotic resistance. Moreover, many limitations of anti-biotics were found when used as acne treatment. For example, tetracycline should be used in a fasting status, and one should avoid taking it with milk. Pregnant women and children are also discouraged from using tetracycline [<xref rid="B10-ijms-18-00141" ref-type="bibr">10</xref>]. Several botanical extracts displayed the anti-skin bacterial effects, such as <italic>Coriandrum sativum</italic> leaf extract, but none of them discussed the multiple therapeutic effects against acne [<xref rid="B11-ijms-18-00141" ref-type="bibr">11</xref>]. In anti-inflammation, non-steroid anti-inflammatory drugs (NSAIDs), such as ibuprofen, diclofenac, and ponstan, are typically used to inhibit biosynthesis of prostaglandin, which is an important mediator in inflammatory reactions. NSAIDs can rapidly decrease the inflammation of acne skin, but the commonest side effects of NSAIDs are peptic ulcers and liver toxicity [<xref rid="B12-ijms-18-00141" ref-type="bibr">12</xref>]. In accordance with previous research, we examined the anti-acne effects of pomegranate extract (PG-E) in vivo and used multiple pathogenic mechanisms of acne vulgaris to establish an anti-acne system model. First, we used HaCaT cells, an immortal human keratinocyte cell line, as a target to simulate testosterone-induced epithelial cells and keratin accumulation. Increased bacterial lipase activity facilitates the synthesis of fatty acids and bacterial growth. In addition, <italic>Propionibacterium acnes</italic> (<italic>P</italic>. <italic>acnes</italic>) and <italic>Staphylococcus aureus</italic> (<italic>S</italic>. <italic>aureus</italic>) are the major pathogenic and most abundant bacteria on the skin surface of acne-affected skin. Eventually, the combination of bacteria with the above-described situations will result in inflammation of the skin. Hence, we used THP-1, a human monocytic cell line, as the target to simulate anti-inflammatory activities against different inducers. The pathogenic mechanism of acne and experimental design of our platform is summarized in <xref ref-type="table" rid="ijms-18-00141-t001">Table 1</xref>. </p><p><italic>Punica granatum</italic> Linne (pomegranate) belongs to the Punicaceae family. In the Mediterranean area, pomegranate is commonly used as a fruit for therapeutic agents, foods, and cosmetics. However, in traditional Chinese medicine, pomegranate was recorded as an astringent agent [<xref rid="B13-ijms-18-00141" ref-type="bibr">13</xref>]. Evidence has shown that the pharmacological effects of pomegranate are its anti-inflammatory, anti-oxidative, anti-lipoperoxidative, anti-bacterial, and anti-tumor activities [<xref rid="B13-ijms-18-00141" ref-type="bibr">13</xref>,<xref rid="B14-ijms-18-00141" ref-type="bibr">14</xref>,<xref rid="B15-ijms-18-00141" ref-type="bibr">15</xref>,<xref rid="B16-ijms-18-00141" ref-type="bibr">16</xref>,<xref rid="B17-ijms-18-00141" ref-type="bibr">17</xref>]. In our previous study, four hydrolysable tannins, punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>), were isolated from pomegranate using column chromatography combined with in vitro anti-inflammatory-guided fractionation [<xref rid="B13-ijms-18-00141" ref-type="bibr">13</xref>]. These four compounds and the 70% acetone pomegranate extract displayed both in vitro and in vivo anti-inflammatory effects. However, few researchers have discussed the anti-acne effects of pomegranate. Therefore, an evaluation platform was used to explore the anti-acne effects of pomegranate. In addition, the principal anti-acne components of pomegranate are also discussed in this study. </p></sec><sec id="sec2-ijms-18-00141"><title>2. Results and Discussion</title><sec id="sec2dot1-ijms-18-00141"><title>2.1. Pomegranate Attenuate P. acnes-Induced Wistar Ear Edema</title><p>In vivo anti-acne effects are difficult to assess because of a lack of animal models. We set up an animal model to simulate acne formation by directly injecting <italic>P</italic>. <italic>acnes</italic> into a rat&#x02019;s ear and evaluated the in vivo anti-acne effects of PG-E. Wistar rat ears exhibit edema when live <italic>P</italic>. <italic>acnes</italic> is injected. As shown in <xref ref-type="fig" rid="ijms-18-00141-f001">Figure 1</xref>, rat ear edema in the PG-E ointment group was significant lower than that in the vehicle control group. In this model, live <italic>P</italic>. <italic>acnes</italic> was injected into Wistar rat ears. We first suggest that PG-E can inhibit the growth of <italic>P</italic>. <italic>acnes</italic>, resulting in a lower inflammatory status and less ear edema.</p></sec><sec id="sec2dot2-ijms-18-00141"><title>2.2. Pomegranate Displayed No Skin Irritation</title><p>As shown in previous studies, a modern therapeutic strategy for acne is to use retinoic acid or salicylic acid. However, skin irritation and desquamation are obvious side-effects of these chemical agents. In this study, a single-dose skin irritation test was performed by modifying the Draize test [<xref rid="B18-ijms-18-00141" ref-type="bibr">18</xref>]. PG-E displayed no skin irritation in Wistar skin at 0.1&#x02013;10 mg/site for 24&#x02013;48 h, indicating the excellent safety of PG-E (data not shown). </p></sec><sec id="sec2dot3-ijms-18-00141"><title>2.3. Pomegranate Significantly Inhibited P. acnes and S. aureus Growth</title><p>Because PG-E significantly attenuated <italic>P</italic>. <italic>acnes</italic>-induced Wistar ear edema, we continued to explore the in vitro activities and try to discover the mechanisms. PG-E displayed stronger anti-bacterial activity against <italic>P</italic>. <italic>acnes</italic> than against <italic>S</italic>. <italic>aureus</italic>. The diameter of the inhibition zone of PG-E against <italic>P</italic>. <italic>acnes</italic> ranged 11.3&#x02013;17.1 mm. Moreover, the inhibition zone of PG-E against <italic>S</italic>. <italic>aureus</italic> ranged 12.6&#x02013;15.9 mm. We calculated the ratio of the inhibition zone compared to penicillin. Ratios of the inhibition zone of PG-E against <italic>S</italic>. <italic>aureus</italic> and <italic>P</italic>. <italic>acnes</italic> were 0.451 and 0.544, respectively (<xref ref-type="table" rid="ijms-18-00141-t002">Table 2</xref>).</p><p>Both the MIC (minimum inhibitory concentration) and MBC (minimum bactericidal concentration) of PG-E against <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> were 62.5 &#x000b5;g/mL. Several researchers showed that pomegranate peel extract displayed significant anti-bacterial effects against <italic>Lactobacillus acidophilus</italic>, <italic>Staphylococcus epidermidis</italic>, <italic>Escherichia coli</italic>, <italic>Salmonella enteritidis</italic>, and <italic>Listeria monocytogenes</italic> [<xref rid="B19-ijms-18-00141" ref-type="bibr">19</xref>,<xref rid="B20-ijms-18-00141" ref-type="bibr">20</xref>,<xref rid="B21-ijms-18-00141" ref-type="bibr">21</xref>]. However, few researchers discussed the anti-bacterial effects of pomegranate against the skin-related bacterium, <italic>P</italic>. <italic>acnes</italic>. This is the first study to explore the anti-<italic>P</italic>. <italic>acnes</italic> effects and try to identify the active components of pomegranate. Through a bioguided-fractionation-isolation system, anti-microbial activities of four hydrolysable tannins in PG-E, punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>), were tested. Results showed that Compounds <bold>1</bold> and <bold>2</bold> have significant anti-bacterial abilities against <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic>, while the MIC of <bold>1</bold> against <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> were 6.25 &#x000b5;g/mL (1.3 &#x000b5;M) and 12.5 &#x000b5;g/mL (2.2 &#x000b5;M); MIC of <bold>2</bold> against <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> were 6.25 &#x000b5;g/mL (1.3 &#x000b5;M) and 12.5 &#x000b5;g/mL (2.2 &#x000b5;M), respectively. Compounds <bold>3</bold> and <bold>4</bold> were less effective against <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> (<xref ref-type="table" rid="ijms-18-00141-t003">Table 3</xref>). In Reddy et al.&#x02019;s study [<xref rid="B15-ijms-18-00141" ref-type="bibr">15</xref>], Compounds <bold>1</bold> and <bold>2</bold> were also isolated from pomegranate juice. Compound <bold>1</bold> displayed significant anti-bacterial effects against <italic>Pseudomonas aeruginosa</italic>, <italic>Candida albicans</italic>, and <italic>Cryptococcus neoformans</italic>. Anti-oxidative effects were also found for <bold>1</bold> and <bold>2</bold>, suggesting that PG-E can act to augment human&#x02019;s anti-bacterial and anti-oxidative capacities [<xref rid="B15-ijms-18-00141" ref-type="bibr">15</xref>]. Anti-acne bacteria effects of tannin compounds in herbal extracts are also well-reported, i.e., tannin components from <italic>Cassia tora</italic>, <italic>Garcinia mangostana</italic>, <italic>Momordica charantia</italic>, <italic>Phyllanthus emblica</italic>, and <italic>Terminalia arjuna</italic> [<xref rid="B22-ijms-18-00141" ref-type="bibr">22</xref>]. However, hydrolysable tannins in pomegranate are firstly reported for their multiple activities against acne in this study. </p></sec><sec id="sec2dot4-ijms-18-00141"><title>2.4. Pomegranate Polyphenols Caused Shrinkage and Damage in P. acnes and S. aureus</title><p>Morphological changes are a clear indicator for monitoring the process of bacterial death. SEM, a powerful electron microscope, can be used to investigate diversification of a bacterium&#x02019;s shape. Differences between treatments with four hydrolysable tannins in <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> are illustrated in <xref ref-type="fig" rid="ijms-18-00141-f002">Figure 2</xref>. As shown in <xref ref-type="fig" rid="ijms-18-00141-f002">Figure 2</xref>A, outer membranes of the control group were smooth and rod-shaped. However, after treatment with <bold>1</bold> or <bold>2</bold> (100 &#x000b5;g/mL) for 12 h, <italic>S</italic>. <italic>aureus</italic> produced around grains and exhibited bulging or deformation of its spherical shape. Intra-inclusions were found to have effluxed outside (representatives are indicated by arrows), and the bacteria were obviously swollen. In Rabie et al.&#x02019;s study, the bacterial structure is an important point for its normal physiology, such as the outer membrane integrity [<xref rid="B23-ijms-18-00141" ref-type="bibr">23</xref>]. We suggested that hydrolysable tannins in pomegranate damaged the structural integrity and bacterial proteins, leading to changes in the integrity and function of bacteria. Compounds <bold>1</bold> and <bold>2</bold> also significantly inhibited the growth of <italic>P</italic>. <italic>acnes</italic> (<xref ref-type="fig" rid="ijms-18-00141-f002">Figure 2</xref>B). However, <italic>P</italic>. <italic>acnes</italic> originally had a spherical shape and displayed a smooth, complete surface. The bacterial surface exhibited obvious shrinkage, damage to the surroundings, and increased granules after treatment with <bold>1</bold> and <bold>2</bold> for 12 h. Biofilms of bacteria play an important role in their virulence and pathogenicity. Another anti-bacterial strategy is to inhibit biofilm formation. It was reported that pomegranate significantly decreases biofilm formation by <italic>S</italic>. <italic>aureus</italic> [<xref rid="B24-ijms-18-00141" ref-type="bibr">24</xref>]. Anti-biofilm formation capacities of pomegranate will be an important target in future studies.</p></sec><sec id="sec2dot5-ijms-18-00141"><title>2.5. Pomegranate Polyphenols Inhibited Lipase Activity</title><p>Lipase is an enzyme that hydrolyzes lipids. Some bacteria, such as <italic>P</italic>. <italic>acnes</italic>, can secrete lipase to resolve lipids and facilitate lipid-related nutrient absorption from an external medium. In this study, a fluorometric assay of lipase activity was administrated with and without PG-E and the four hydrolysable tannins. Compared to the control, PG-E (200 &#x000b5;g/mL) inhibited lipase activity by 20% as shown by a decrease in lipase substrate degradation. The anti-lipase effects of the essential oil compositions of pomegranate peel extracts have been previously reported, but the principle active principle components were not discussed [<xref rid="B25-ijms-18-00141" ref-type="bibr">25</xref>]. In this study, three hydrolysable tannins, 1, 3, and 4, at 200 &#x000b5;g/mL significantly inhibited the lipase activity by 39.8%, 34.7%, and 35.2%, respectively (<xref ref-type="fig" rid="ijms-18-00141-f003">Figure 3</xref>).</p></sec><sec id="sec2dot6-ijms-18-00141"><title>2.6. Pomegranate Polyphenols Inhibited HaCaT Cell Proliferation</title><p>Because keratinocyte over-proliferation is a crucial event in acne formation, testosterone was used as an inducer to stimulate HaCaT cell proliferation. Results showed that testosterone time- and dose-dependently induced HaCaT cell proliferation. Further, testosterone significantly induced proliferation of keratinocytes at 10 and 100 &#x000b5;g/mL for 72 h (<xref ref-type="fig" rid="ijms-18-00141-f004">Figure 4</xref>). </p><p>Therefore, treatment with testosterone at 10 &#x000b5;g/mL for 72 h was used to assess which hydrolysable tannins could inhibit HaCaT cell proliferation. Result showed that four hydrolysable tannins could significantly decrease the testosterone-induced HaCaT cell proliferation at 50 &#x000b5;g/mL (<xref ref-type="fig" rid="ijms-18-00141-f005">Figure 5</xref>). Two research teams discussed the protective effects of pomegranate against UV-induced HaCaT oxidative stress and markers of photoaging [<xref rid="B26-ijms-18-00141" ref-type="bibr">26</xref>,<xref rid="B27-ijms-18-00141" ref-type="bibr">27</xref>]. Taken together with results of this study, we suggest that pomegranate can act as a UV protector and growth regulator of skin keratinocytes.</p></sec><sec id="sec2dot7-ijms-18-00141"><title>2.7. Pomegranate Polyphenols Attenuated Heat-Killed P. acnes-Induced NO and PGE<sub>2</sub> Production by RAW 264.7 Cells</title><p>In our previous study, we showed the anti-inflammatory effects of PG-E and four hydrolysable tannins against LPS (lipopolysaccharide)-treated RAW 264.7 cells [<xref rid="B12-ijms-18-00141" ref-type="bibr">12</xref>]. Moreover, in this study, we used HKP (heat-killed <italic>P</italic>. <italic>acnes</italic>), instead of LPS, to simulate the irritation and inflammation caused by a <italic>P</italic>. <italic>acnes</italic> infection. As shown in <xref ref-type="fig" rid="ijms-18-00141-f006">Figure 6</xref>A,B, HKP at 25&#x02013;200 &#x000b5;g/mL dose-dependently and significantly induced NO (nitric oxide) and PGE<sub>2</sub> (Prostaglandin E<sub>2</sub>) production by RAW 264.7 cells. However, a good relationship between the inflammatory response and the dose of HKP occurred at 50&#x02013;200 &#x000b5;g/mL. Ultimately, we chose 100 &#x000b5;g/mL of HKP as our inflammation induction dosage. Compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> at 50 &#x000b5;M displayed over 50% NO inhibitory effects against HKP-induced RAW 264.7 cells (<xref ref-type="fig" rid="ijms-18-00141-f006">Figure 6</xref>C). In addition, <bold>1</bold> and <bold>4</bold> at 50 &#x000b5;M also significantly inhibited about 50% of PGE<sub>2</sub> production in HKP-treated RAW 264.7 cells (<xref ref-type="fig" rid="ijms-18-00141-f006">Figure 6</xref>D).</p></sec><sec id="sec2dot8-ijms-18-00141"><title>2.8. Pomegranate Polyphenols Attenuated Heat-Killed P. acnes-Induced IL-8 and TNF-&#x003b1; Production by THP-1 Cells</title><p>Cytokine, such as IL-8 (interleukin 8) and TNF-&#x003b1; (tumor necrosis factor-&#x003b1;), releases are also key points in the inflammatory status of human acne lesions [<xref rid="B28-ijms-18-00141" ref-type="bibr">28</xref>]. As shown in <xref ref-type="fig" rid="ijms-18-00141-f007">Figure 7</xref>, HKP (100 &#x000b5;g/mL) obviously induced IL-8 and TNF-&#x003b1; production in a human monocytic cell line. In <xref ref-type="fig" rid="ijms-18-00141-f007">Figure 7</xref>A, the four hydrolysable tannins inhibited IL-8 and TNF-&#x003b1; production in dose-dependent manners at 50&#x02013;200 &#x000b5;g/mL, and compound <bold>4</bold> had the strongest inhibitory activity. Anti-TNF-&#x003b1; activities of pomegranate polyphenols are shown in <xref ref-type="fig" rid="ijms-18-00141-f007">Figure 7</xref>B. Compounds <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> exhibited significant inhibitory activities against TNF-&#x003b1; production, with <bold>4</bold> also displaying the strongest effect. This is the first time that Compound <bold>4</bold> has been reported to have anti-inflammatory cytokine effects. </p></sec></sec><sec id="sec3-ijms-18-00141"><title>3. Materials and Methods </title><sec id="sec3dot1-ijms-18-00141"><title>3.1. General</title><p>Four active components of pomegranate, punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>), were isolated and identified in our previous study (<xref ref-type="fig" rid="ijms-18-00141-f003">Figure 3</xref>) [<xref rid="B13-ijms-18-00141" ref-type="bibr">13</xref>]. 3-(4.5-Dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), lipopolysaccharide (LPS), and other chemicals were purchased from Sigma Industries (Saint Louis, MO, USA). Dulbecco&#x02019;s modified Eagle medium (DMEM), Roswell Park Memorial Institute (RPMI) medium, fetal bovine serum (FBS), anti-biotics, and glutamine were purchased from GIBCO BRL (Grand Island, NY, USA). The bacterial culture equipment, including an anaerobic atmosphere by MGC AnaeroPack-Anaero and MGC AnaeroPack-Jar, were purchased from Mitsubishi Gas Chemical Company (Tokyo, Japan). Blood agar plates (BAPs), Bacto&#x02122; tryptic soy broth (TSB), and Bacto&#x02122; tryptic soy agar (TSA) were purchased from Difco (Detroit, MI, USA). The assay kits for tumor necrosis factor (TNF)-&#x003b1;, interleukin (IL)-1&#x003b2;, and IL-8 were purchased from eBioscience (San Diego, CA, USA). </p></sec><sec id="sec3dot2-ijms-18-00141"><title>3.2. Preparation of Pomegranate Extract (PG-E)</title><p>Dried peels of pomegranate were purchased from a traditional Chinese medicine store in Taipei and identified by Hsien-Chang Chang. A voucher specimen (PG-01) was deposited in the School of Pharmacy, College of Pharmacy, Taipei Medical University (Taipei, Taiwan). Dried peels were extracted by homogenization with 70% acetone. The extracted solution was filtered, evaporated on a rotary evaporator, lyophilized, and called PG-E. PG-E and its active components were dissolved in 10% DMSO to a concentration of 10 mg/mL for subsequent experiments, stored at 4 &#x000b0;C, and used within 1 month. Serial dilutions of test solutions with culture medium were prepared before the in vitro assays. </p></sec><sec id="sec3dot3-ijms-18-00141"><title>3.3. P. acnes-Induced Ear Edema in Wistar Rats</title><p>The animal use protocol was reviewed and approved by the institutional Animal Care and Use Committee or Panel (IACUC/IACUP), Taipei Medical University (IACUC Approval no. LAC-97-0122). All methods involved in animal experiments were performed in accordance with the previous relevant guidelines and regulations. Female Wistar rats weighing 250 &#x000b1; 20 g were bought from BioLASCO Taiwan (Yilan, Taiwan) and kept on a 12 h light/12 h dark cycle at 21 &#x000b1; 2 &#x000b0;C with food and water ad libitum. <italic>P</italic>. <italic>acnes</italic> (8 &#x000d7; 10<sup>7</sup> colony-forming units (CFU)/20 &#x000b5;L) was intradermally injected into the left ear of rats to induce edema (<xref ref-type="fig" rid="ijms-18-00141-f008">Figure 8</xref>). PBS (phosphate-buffered saline) was injected into the right ear as a vehicle control [<xref rid="B29-ijms-18-00141" ref-type="bibr">29</xref>]. One hour before the injection, PG-E ointment (10% PG-E in hydrophilic ointment) was administered (eight rats per group) on the skin surfaces of the left ear. The perimeter of the ear edema included diameter and height after <italic>P</italic>. <italic>acnes</italic> or PBS injection after 1&#x02013;4 days were measured by calipers. Volume of ear edema could be calculated using multiplication by diameter, height, and circular constant. In the vehicle control group, the rat ear edema reduce volume was calculated as the original volume of ear edema after the PBS injection minus the volume of ear edema after injection on days 1, 2, 3, and 4. In the PG-E ointment group, the rat ear edema reduce volume was calculated as the original volume of ear edema after the <italic>P</italic>. <italic>acnes</italic> injection minus the volume of ear edema administrated with PG-E ointment after injection on days 1, 2, 3, and 4. </p></sec><sec id="sec3dot4-ijms-18-00141"><title>3.4. Skin Irritation</title><p>The skin toxicity of PG-E was evaluated from a single topical application in Wistar rats. Twenty-four hours before the test, the backs of rats were shaved free of hair (2.5 &#x000d7; 2.5 cm<sup>2</sup> at each site) and checked for any abnormalities (integrity and allergies). An appropriate concentration of PG-E (50 &#x000b5;L per sample) was smeared onto the shaved back of a Wistar rat. The patches were secured for a 4 h exposure period and removed with distilled water. At 24 h and 48 h after the application of PG-E, skin irritation was observed, and the extent of the evident skin allergic reaction was evaluated for each test animal. The acute primary irritation test was applied following the classic Draize test [<xref rid="B17-ijms-18-00141" ref-type="bibr">17</xref>]. </p></sec><sec id="sec3dot5-ijms-18-00141"><title>3.5. Anti-Bacterial Activities against P. acnes and S. aureus</title><p><italic>P</italic>. <italic>acnes</italic> (BCRC10723) and <italic>S</italic>. <italic>aureus</italic> (BCRC 10781) were obtained from the Bioresource Collection and Research Center (Hsinchu, Taiwan). <italic>P</italic>. <italic>acnes</italic> was cultured in BAP with an anaerobic atmosphere using MGC AnaeroPack-Anaero and MGC AnaeroPack-Jar (Mitsubishi Gas Chemical Company). <italic>S</italic>. <italic>aureus</italic> was cultured in Bacto&#x02122; TSB (Difco). PG-E, punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>) were tested against <italic>P</italic>. <italic>acnes</italic> by the paper disc-diffusion method. All experimental procedures were performed according to our previous study with slight modification [<xref rid="B17-ijms-18-00141" ref-type="bibr">17</xref>]. Freshly grown <italic>P</italic>. <italic>acnes</italic> was diluted with Bacto&#x02122; TSB, and 10 mL of prepared bacteria (4 &#x000d7; 10<sup>8</sup> CFU/mL) was aseptically added to 90 mL of sterilized media (TSA) at 45 &#x000b0;C in a water bath. The seeded agar media were immediately mixed and poured into a Petri dish. Prepared sample discs (8 mm in diameter) were added. In addition, 10 U of penicillin was used as the positive control. Plates were incubated under anaerobic conditions at 37 &#x000b0;C for 24 h, and inhibition zones in millimeters were measured. Each experiment was repeated in triplicate. The experimental protocol of anti-<italic>S</italic>. <italic>aureus</italic> (0.5 &#x000d7; 10<sup>8</sup> CFU/mL) activities was the same as that described above with some modifications. The anti-bacterial activity is expressed as the diameter of the inhibition zone against the test microorganisms as follows: ratio (%) = (diameter zone of sample/diameter zone of penicillin) &#x000d7; 100. An inoculation loop was used to collect bacteria from the clear zone on an agar plate. The inoculation loop was enriched in TSB for 24 h. At the end of incubation, TSB was put onto the surface of nutrient agar plates and incubated at 37 &#x000b0;C for 24 h. The minimum bactericidal concentration (MBC) was estimated as the lowest concentration of the samples where no visible growth was observed. The minimum inhibitory concentration (MIC) was estimated as the lowest concentration of the samples where visible growth was observed. </p></sec><sec id="sec3dot6-ijms-18-00141"><title>3.6. Scanning Electron Microscopy (SEM)</title><p><italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> were cultured in TSB to the exponential phase. After counting bacterial numbers, <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> were seeded in 96-well plates and incubated with samples at 37 &#x000b0;C for 12 h. The culture broth was centrifuged at 10,000 rpm for 10 min and washed with phosphate-buffered saline (PBS) twice. Pellets were fixed with 2.5% buffered glutaraldehyde at 4 &#x000b0;C for 2 h and then post-fixed in 1% buffered osmium tetroxide for 2 h. After the fixation process, bacteria were dehydrated in a graded series of ethanol concentrations (35%, 50%, 70%, 85%, 95%, and 100%, <italic>w</italic>/<italic>v</italic>), and these solvents were replaced in turn with liquid carbon dioxide by critical point drying. After mounting onto carbon stubs and vacuum sputter-coating with gold, the samples were analyzed with a Hitachi S-2400N SEM (Tokyo, Japan) under standard operating conditions. </p></sec><sec id="sec3dot7-ijms-18-00141"><title>3.7. Anti-Lipase Activity</title><p>Anti-lipase activity was evaluated by a fluorometric assay. PG-E and its active components were reacted with a lipase solution (100 U/mL) and a 4-methylumbelliferyl butyrate solution (10 &#x000b5;M), and the reaction was terminated using sodium citrate (0.1 M) [<xref rid="B30-ijms-18-00141" ref-type="bibr">30</xref>]. Fluorescence was detected in a fluorometric microplate reader (&#x003bb;ex: 365 nm, &#x003bb;em: 445 nm). Each experiment was performed in triplicate. Results are expressed as the mean &#x000b1; standard deviation (SD), and the percentage of inhibition was compared to the control.</p></sec><sec id="sec3dot8-ijms-18-00141"><title>3.8. Anti-Proliferative Activity against Testosterone-Treated HaCaT Cells</title><p>HaCaT cells, a human keratinocyte cell line, were cultured in DMEM with 10% FBS, 1% penicillin-streptomycin, and 1% <sc>l</sc>-glutamine at 37 &#x000b0;C and 5% CO<sub>2</sub>. HaCaT cells (2 &#x000d7; 10<sup>4</sup> cells/well) were seeded in 96-well plates and co-treated with testosterone (10 &#x000b5;g/mL), and test samples were incubated for 18 h [<xref rid="B31-ijms-18-00141" ref-type="bibr">31</xref>]. Cell proliferative activity was detected by an MTT assay.</p></sec><sec id="sec3dot9-ijms-18-00141"><title>3.9. Anti-Inflammatory Activity against Heat-Killed P. acnes-Treated RAW 264.7 Cells</title><p><italic>P</italic>. <italic>acnes</italic> (4 &#x000d7; 10<sup>8</sup> CFU/mL) was incubated at 80 &#x000b0;C for 30 min to prepare heat-killed <italic>P</italic>. <italic>acnes</italic> (HKP). The HKP was freeze-dried and stored at 4 &#x000b0;C until use. RAW 264.7 cells (BCRC-60001) were cultured in DMEM with 10% FBS, 1% penicillin-streptomycin, and 1% <sc>l</sc>-glutamine at 37 &#x000b0;C and 5% CO<sub>2</sub>. RAW 264.7 cells (8 &#x000d7; 10<sup>4</sup> cells/well) were seeded in 96-well plates and co-treated with HKP (100 &#x000b5;g/mL) and test samples [<xref rid="B32-ijms-18-00141" ref-type="bibr">32</xref>]. After 18 h, nitric oxide (NO) production was determined by mixing the cell culture medium with a Griess reagent, and the absorption was detected in an enzyme-linked immunosorbent assay (ELISA) reader at 530 nm. Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) concentrations in cell culture media were determined with a PGE<sub>2</sub> ELISA kit (Enzo Life Sciences, Farmingdale, NY, USA). Cell viability was detected by an MTT assay.</p></sec><sec id="sec3dot10-ijms-18-00141"><title>3.10. Anti-Inflammatory Activity against Heat-Killed P. acnes-Treated THP-1 Cells</title><p>THP-1 cells, a human monocytic cell line (BCRC-60430), were cultured in RPMI with 10% FBS, 1% penicillin-streptomycin, and 1% <sc>l</sc>-glutamine at 37 &#x000b0;C and 5% CO<sub>2</sub>. THP-1 cells (1 &#x000d7; 10<sup>6</sup> cells/well) were seeded in 24-well plates and co-treated with HKP (100 &#x000b5;g/mL) and test samples for 18 h. TNF-&#x003b1; and IL-8 concentrations of cell culture media were determined by respective enzyme immunoassay kits.</p></sec><sec id="sec3dot11-ijms-18-00141"><title>3.11. Statistical Analysis</title><p>Data are presented as the mean and SD. Significance was calculated using Student&#x02019;s <italic>t</italic>-test and a one-way analysis of variance (ANOVA) by SPSS software v.15 (SPSS, Chicago, IL, USA).</p></sec></sec><sec id="sec4-ijms-18-00141"><title>4. Conclusions</title><p>In this study, we used several approaches to explore the multiple therapeutic effects of PG-E against <italic>P</italic>. <italic>acnes</italic>. Our results showed that PG-E directly attenuated <italic>P</italic>. <italic>acnes</italic>-induced Wistar ear edema in vivo and inhibited the growth of acne-related bacteria, i.e., <italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic>, down-regulated sebum production by reducing lipase activity, attenuated the inflammatory status, and avoided keratinocyte over-proliferation in vitro. Taken together, we suggest that the 70% acetone PG-E showed multiple anti-acne capacities, including anti-bacterial, anti-lipase, anti-keratinocyte proliferation, and anti-inflammatory actions. Four hydrolysable tannins, punicalagin, punicalin, strictinin A, and granatin B, were isolated from 70% acetone PG-E and exhibited different anti-acne effects. However, punicalagin, which had the highest effect on various functions, can be employed as a quality control marker. Pomegranate has great potential to be developed as a dietary supplement and for use in skin-care products. </p></sec></body><back><notes><title>Author Contributions</title><p>Chia-Jung Lee and Ching-Chiung Wang: study design, in vitro and in vivo experiments, manuscript drafting and revising; Lih-Geeng Chen: compound isolation from pomegranate; Wen-Li Liang: Panti-bacterial experiments; All authors reviewed the manuscripts.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. </p></notes><ref-list><title>References</title><ref id="B1-ijms-18-00141"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>James</surname><given-names>W.D.</given-names></name></person-group>
<article-title>Clinical practice: Acne</article-title>
<source>N. Engl. J. Med.</source>
<year>2005</year>
<volume>352</volume>
<fpage>1463</fpage>
<lpage>1472</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMcp033487</pub-id>
<?supplied-pmid 15814882?><pub-id pub-id-type="pmid">15814882</pub-id></element-citation></ref><ref id="B2-ijms-18-00141"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pappas</surname><given-names>A.</given-names></name></person-group>
<article-title>Epidermal surface lipids</article-title>
<source>Dermatoendocrinology</source>
<year>2009</year>
<volume>1</volume>
<fpage>72</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.4161/derm.1.2.7811</pub-id>
</element-citation></ref><ref id="B3-ijms-18-00141"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Bowe</surname><given-names>W.P.</given-names></name><name><surname>Heughebaert</surname><given-names>C.</given-names></name><name><surname>Shalita</surname><given-names>A.R.</given-names></name></person-group>
<article-title>The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: A review</article-title>
<source>J. Drugs Dermatol.</source>
<year>2010</year>
<volume>9</volume>
<fpage>655</fpage>
<lpage>664</lpage>
<?supplied-pmid 20645527?><pub-id pub-id-type="pmid">20645527</pub-id></element-citation></ref><ref id="B4-ijms-18-00141"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Youn</surname><given-names>S.W.</given-names></name></person-group>
<article-title>The role of facial sebum secretion in acne pathogenesis: Facts and controversies</article-title>
<source>Clin. Dermatol.</source>
<year>2010</year>
<volume>28</volume>
<fpage>8</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/j.clindermatol.2009.03.011</pub-id>
<?supplied-pmid 20082943?><pub-id pub-id-type="pmid">20082943</pub-id></element-citation></ref><ref id="B5-ijms-18-00141"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olutunmbi</surname><given-names>Y.</given-names></name><name><surname>Paley</surname><given-names>K.</given-names></name><name><surname>English</surname><given-names>J.C.</given-names><suffix>3rd</suffix></name></person-group>
<article-title>Adolescent female acne: Etiology and management</article-title>
<source>J. Pediatr. Adolesc. Gynecol.</source>
<year>2008</year>
<volume>21</volume>
<fpage>171</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpag.2007.07.004</pub-id>
<?supplied-pmid 18656070?><pub-id pub-id-type="pmid">18656070</pub-id></element-citation></ref><ref id="B6-ijms-18-00141"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leccia</surname><given-names>M.T.</given-names></name><name><surname>Auffret</surname><given-names>N.</given-names></name><name><surname>Poli</surname><given-names>F.</given-names></name><name><surname>Claudel</surname><given-names>J.P.</given-names></name><name><surname>Corvec</surname><given-names>S.</given-names></name><name><surname>Dreno</surname><given-names>B.</given-names></name></person-group>
<article-title>Topical acne treatments in Europe and the issue of antimicrobial resistance</article-title>
<source>J. Eur. Acad. Dermatol. Venereol.</source>
<year>2015</year>
<volume>29</volume>
<fpage>1485</fpage>
<lpage>1492</lpage>
<pub-id pub-id-type="doi">10.1111/jdv.12989</pub-id>
<?supplied-pmid 25677763?><pub-id pub-id-type="pmid">25677763</pub-id></element-citation></ref><ref id="B7-ijms-18-00141"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwon</surname><given-names>H.H.</given-names></name><name><surname>Yoon</surname><given-names>J.Y.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Min</surname><given-names>S.</given-names></name><name><surname>Suh</surname><given-names>D.H.</given-names></name></person-group>
<article-title>Comparison of clinical and histological effects between lactobacillus-fermented <italic>Chamaecyparis obtusa</italic> and tea tree oil for the treatment of acne: An eight-week double-blind randomized controlled split-face study</article-title>
<source>Dermatology</source>
<year>2014</year>
<volume>229</volume>
<fpage>102</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1159/000362491</pub-id>
<?supplied-pmid 25228478?><pub-id pub-id-type="pmid">25228478</pub-id></element-citation></ref><ref id="B8-ijms-18-00141"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ha</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Seo</surname><given-names>C.S.</given-names></name><name><surname>Lim</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>M.Y.</given-names></name><name><surname>Shin</surname><given-names>H.</given-names></name></person-group>
<article-title><italic>Artemisia capillaris</italic> inhibits atopic dermatitis-like skin lesions in Dermatophagoides farinae-sensitized Nc/Nga mice</article-title>
<source>BMC Complement. Altern. Med.</source>
<year>2014</year>
<volume>14</volume>
<elocation-id>100</elocation-id>
<pub-id pub-id-type="doi">10.1186/1472-6882-14-100</pub-id>
<?supplied-pmid 24624888?><pub-id pub-id-type="pmid">24624888</pub-id></element-citation></ref><ref id="B9-ijms-18-00141"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kornhauser</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>R.R.</given-names></name><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name><name><surname>Coelho</surname><given-names>S.G.</given-names></name><name><surname>Kaidbey</surname><given-names>K.</given-names></name><name><surname>Barton</surname><given-names>C.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Beer</surname><given-names>J.Z.</given-names></name><name><surname>Miller</surname><given-names>S.A.</given-names></name><name><surname>Hearing</surname><given-names>V.J.</given-names></name></person-group>
<article-title>The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin</article-title>
<source>J. Dermatol. Sci.</source>
<year>2009</year>
<volume>55</volume>
<fpage>10</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.jdermsci.2009.03.011</pub-id>
<?supplied-pmid 19411163?><pub-id pub-id-type="pmid">19411163</pub-id></element-citation></ref><ref id="B10-ijms-18-00141"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plewig</surname><given-names>G.</given-names></name><name><surname>Holland</surname><given-names>K.T.</given-names></name><name><surname>Nenoff</surname><given-names>P.</given-names></name></person-group>
<article-title>Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: A double-blind, phase III comparison study versus erythromycin 2% cream</article-title>
<source>Eur. J. Dermatol.</source>
<year>2006</year>
<volume>16</volume>
<fpage>48</fpage>
<lpage>55</lpage>
<?supplied-pmid 16436342?><pub-id pub-id-type="pmid">16436342</pub-id></element-citation></ref><ref id="B11-ijms-18-00141"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sathishkumar</surname><given-names>P.</given-names></name><name><surname>Preethi</surname><given-names>J.</given-names></name><name><surname>Vijayan</surname><given-names>R.</given-names></name><name><surname>Mohd Yusoff</surname><given-names>A.R.</given-names></name><name><surname>Ameen</surname><given-names>F.</given-names></name><name><surname>Suresh</surname><given-names>S.</given-names></name><name><surname>Balagurunathan</surname><given-names>R.</given-names></name><name><surname>Palvannan</surname><given-names>T.</given-names></name></person-group>
<article-title>Anti-acne, anti-dandruff and anti-breast cancer efficacy of green synthesised silver nanoparticles using <italic>Coriandrum sativum</italic> leaf extract</article-title>
<source>J. Photochem. Photobiol. B</source>
<year>2016</year>
<volume>163</volume>
<fpage>69</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.jphotobiol.2016.08.005</pub-id>
<?supplied-pmid 27541567?><pub-id pub-id-type="pmid">27541567</pub-id></element-citation></ref><ref id="B12-ijms-18-00141"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Onumah</surname><given-names>N.</given-names></name></person-group>
<article-title>A novel anti-inflammatory in treatment of acne vulgaris: the pseudopterosins</article-title>
<source>J. Drugs Dermatol.</source>
<year>2013</year>
<volume>12</volume>
<fpage>1177</fpage>
<lpage>1179</lpage>
<?supplied-pmid 24085056?><pub-id pub-id-type="pmid">24085056</pub-id></element-citation></ref><ref id="B13-ijms-18-00141"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>L.G.</given-names></name><name><surname>Liang</surname><given-names>W.L.</given-names></name><name><surname>Wang</surname><given-names>C.C.</given-names></name></person-group>
<article-title>Anti-inflammatory effects of <italic>Punica granatum</italic> Linne in vitro and in vivo</article-title>
<source>Food Chem.</source>
<year>2010</year>
<volume>118</volume>
<fpage>315</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodchem.2009.04.123</pub-id>
</element-citation></ref><ref id="B14-ijms-18-00141"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lansky</surname><given-names>E.P.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name></person-group>
<article-title><italic>Punica granatum</italic> (pomegranate) and its potential for prevention and treatment of inflammation and cancer</article-title>
<source>J. Ethnopharmacol.</source>
<year>2007</year>
<volume>109</volume>
<fpage>177</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2006.09.006</pub-id>
<?supplied-pmid 17157465?><pub-id pub-id-type="pmid">17157465</pub-id></element-citation></ref><ref id="B15-ijms-18-00141"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>M.K.</given-names></name><name><surname>Gupta</surname><given-names>S.K.</given-names></name><name><surname>Jacob</surname><given-names>M.R.</given-names></name><name><surname>Khan</surname><given-names>S.I.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name></person-group>
<article-title>Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from <italic>Punica granatum</italic> L.</article-title>
<source>Planta Med.</source>
<year>2007</year>
<volume>73</volume>
<fpage>461</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1055/s-2007-967167</pub-id>
<?supplied-pmid 17566148?><pub-id pub-id-type="pmid">17566148</pub-id></element-citation></ref><ref id="B16-ijms-18-00141"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menezes</surname><given-names>S.M.</given-names></name><name><surname>Cordeiro</surname><given-names>L.N.</given-names></name><name><surname>Viana</surname><given-names>G.S.</given-names></name></person-group>
<article-title><italic>Punica granatum</italic> (pomegranate) extract is active against dental plaque</article-title>
<source>J. Herb. Pharmacother.</source>
<year>2006</year>
<volume>6</volume>
<fpage>79</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1080/J157v06n02_07</pub-id>
<?supplied-pmid 17182487?><pub-id pub-id-type="pmid">17182487</pub-id></element-citation></ref><ref id="B17-ijms-18-00141"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.J.</given-names></name><name><surname>Chen</surname><given-names>L.W.</given-names></name><name><surname>Chen</surname><given-names>L.G.</given-names></name><name><surname>Chang</surname><given-names>T.L.</given-names></name><name><surname>Huang</surname><given-names>C.W.</given-names></name><name><surname>Huang</surname><given-names>M.C.</given-names></name><name><surname>Wang</surname><given-names>C.C.</given-names></name></person-group>
<article-title>Correlations of the components of tea tree oil with its antibacterial effects and skin irritation</article-title>
<source>J. Food Drug Anal.</source>
<year>2013</year>
<volume>21</volume>
<fpage>169</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.jfda.2013.05.007</pub-id>
</element-citation></ref><ref id="B18-ijms-18-00141"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>N.</given-names></name><name><surname>Afaq</surname><given-names>F.</given-names></name><name><surname>Kweon</surname><given-names>M.H.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group>
<article-title>Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice</article-title>
<source>Cancer Res.</source>
<year>2007</year>
<volume>67</volume>
<fpage>3475</fpage>
<lpage>3482</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-3941</pub-id>
<?supplied-pmid 17389758?><pub-id pub-id-type="pmid">17389758</pub-id></element-citation></ref><ref id="B19-ijms-18-00141"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abdollahzadeh</surname><given-names>S.H.</given-names></name><name><surname>Mashouf</surname><given-names>R.</given-names></name><name><surname>Mortazavi</surname><given-names>H.</given-names></name><name><surname>Moghaddam</surname><given-names>M.</given-names></name><name><surname>Roozbahani</surname><given-names>N.</given-names></name><name><surname>Vahedi</surname><given-names>M.</given-names></name></person-group>
<article-title>Antibacterial and antifungal activities of <italic>Punica granatum</italic> peel extracts against oral pathogens</article-title>
<source>J. Dent. (Tehran)</source>
<year>2011</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">21998800</pub-id></element-citation></ref><ref id="B20-ijms-18-00141"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fawole</surname><given-names>O.A.</given-names></name><name><surname>Makunga</surname><given-names>N.P.</given-names></name><name><surname>Opara</surname><given-names>U.L.</given-names></name></person-group>
<article-title>Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract</article-title>
<source>BMC Complement. Altern. Med.</source>
<year>2012</year>
<volume>12</volume>
<elocation-id>200</elocation-id>
<pub-id pub-id-type="doi">10.1186/1472-6882-12-200</pub-id>
<?supplied-pmid 23110485?><pub-id pub-id-type="pmid">23110485</pub-id></element-citation></ref><ref id="B21-ijms-18-00141"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Zoreky</surname><given-names>N.S.</given-names></name></person-group>
<article-title>Antimicrobial activity of pomegranate (<italic>Punica granatum</italic> L.) fruit peels</article-title>
<source>Int. J. Food Microbiol.</source>
<year>2009</year>
<volume>134</volume>
<fpage>244</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2009.07.002</pub-id>
<?supplied-pmid 19632734?><pub-id pub-id-type="pmid">19632734</pub-id></element-citation></ref><ref id="B22-ijms-18-00141"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Azimi</surname><given-names>H.</given-names></name><name><surname>Fallah-Tafti</surname><given-names>M.</given-names></name><name><surname>Khakshur</surname><given-names>A.A.</given-names></name><name><surname>Abdollahi</surname><given-names>M.</given-names></name></person-group>
<article-title>A review of phytotherapy of acne vulgaris: Perspective of new pharmacological treatments</article-title>
<source>Fitoterapia</source>
<year>2012</year>
<volume>83</volume>
<fpage>1306</fpage>
<lpage>1317</lpage>
<pub-id pub-id-type="doi">10.1016/j.fitote.2012.03.026</pub-id>
<?supplied-pmid 22521501?><pub-id pub-id-type="pmid">22521501</pub-id></element-citation></ref><ref id="B23-ijms-18-00141"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rabie</surname><given-names>E.</given-names></name><name><surname>Serem</surname><given-names>J.C.</given-names></name><name><surname>Oberholzer</surname><given-names>H.M.</given-names></name><name><surname>Gaspar</surname><given-names>A.R.</given-names></name><name><surname>Bester</surname><given-names>M.J.</given-names></name></person-group>
<article-title>How methylglyoxal kills bacteria: An ultrastructural study</article-title>
<source>Ultrastruct. Pathol.</source>
<year>2016</year>
<volume>40</volume>
<fpage>107</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.3109/01913123.2016.1154914</pub-id>
<?supplied-pmid 26986806?><pub-id pub-id-type="pmid">26986806</pub-id></element-citation></ref><ref id="B24-ijms-18-00141"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bakkiyaraj</surname><given-names>D.</given-names></name><name><surname>Nandhini</surname><given-names>J.R.</given-names></name><name><surname>Malathy</surname><given-names>B.</given-names></name><name><surname>Pandian</surname><given-names>S.K.</given-names></name></person-group>
<article-title>The anti-biofilm potential of pomegranate (<italic>Punica granatum</italic> L.) extract against human bacterial and fungal pathogens</article-title>
<source>Biofouling</source>
<year>2013</year>
<volume>29</volume>
<fpage>929</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="doi">10.1080/08927014.2013.820825</pub-id>
<?supplied-pmid 23906229?><pub-id pub-id-type="pmid">23906229</pub-id></element-citation></ref><ref id="B25-ijms-18-00141"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hadrich</surname><given-names>F.</given-names></name><name><surname>Cher</surname><given-names>S.</given-names></name><name><surname>Gargouri</surname><given-names>Y.T.</given-names></name><name><surname>Adel</surname><given-names>S.</given-names></name></person-group>
<article-title>Antioxidant and lipase inhibitory activities and essential oil composition of pomegranate peel extracts</article-title>
<source>J. Oleo Sci.</source>
<year>2014</year>
<volume>63</volume>
<fpage>515</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.5650/jos.ess13163</pub-id>
<?supplied-pmid 24770478?><pub-id pub-id-type="pmid">24770478</pub-id></element-citation></ref><ref id="B26-ijms-18-00141"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baccarin</surname><given-names>T.</given-names></name><name><surname>Mitjans</surname><given-names>M.</given-names></name><name><surname>Ramos</surname><given-names>D.</given-names></name><name><surname>Lemos-Senna</surname><given-names>E.</given-names></name><name><surname>Vinardell</surname><given-names>M.P.</given-names></name></person-group>
<article-title>Photoprotection by <italic>Punica granatum</italic> seed oil nanoemulsion entrapping polyphenol-rich ethyl acetate fraction against UVB-induced DNA damage in human keratinocyte (HaCaT) cell line</article-title>
<source>J. Photochem. Photobiol. B</source>
<year>2015</year>
<volume>153</volume>
<fpage>127</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1016/j.jphotobiol.2015.09.005</pub-id>
<?supplied-pmid 26406978?><pub-id pub-id-type="pmid">26406978</pub-id></element-citation></ref><ref id="B27-ijms-18-00141"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaid</surname><given-names>M.A.</given-names></name><name><surname>Afaq</surname><given-names>F.</given-names></name><name><surname>Syed</surname><given-names>D.N.</given-names></name><name><surname>Dreher</surname><given-names>M.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group>
<article-title>Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx</article-title>
<source>Photochem. Photobiol.</source>
<year>2007</year>
<volume>83</volume>
<fpage>882</fpage>
<lpage>888</lpage>
<pub-id pub-id-type="doi">10.1111/j.1751-1097.2007.00157.x</pub-id>
<?supplied-pmid 17645659?><pub-id pub-id-type="pmid">17645659</pub-id></element-citation></ref><ref id="B28-ijms-18-00141"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rottboell</surname><given-names>L.</given-names></name><name><surname>de Foenss</surname><given-names>S.</given-names></name><name><surname>Thomsen</surname><given-names>K.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>Andersen</surname><given-names>S.M.</given-names></name><name><surname>Dam</surname><given-names>T.N.</given-names></name><name><surname>Rosada</surname><given-names>C.</given-names></name><name><surname>Stenderup</surname><given-names>K.</given-names></name></person-group>
<article-title>Exploring valrubicin&#x02019;s effect on <italic>Propionibacterium acnes</italic>-induced skin inflammation in vitro and in vivo</article-title>
<source>Dermatol. Rep.</source>
<year>2015</year>
<volume>7</volume>
<fpage>6246</fpage>
<pub-id pub-id-type="doi">10.4081/dr.2015.6246</pub-id>
<?supplied-pmid 26734122?><pub-id pub-id-type="pmid">26734122</pub-id></element-citation></ref><ref id="B29-ijms-18-00141"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Lv</surname><given-names>X.D.</given-names></name><name><surname>Wang</surname><given-names>G.E.</given-names></name><name><surname>Li</surname><given-names>Y.F.</given-names></name><name><surname>Kurihara</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>R.R.</given-names></name></person-group>
<article-title>Anti-inflammatory effects of anthocyanins-rich extract from bilberry (<italic>Vaccinium myrtillus</italic> L.) on croton oil-induced ear edema and <italic>Propionibacterium acnes</italic> plus LPS-induced liver damage in mice</article-title>
<source>Int. J. Food Sci. Nutr.</source>
<year>2014</year>
<volume>65</volume>
<fpage>594</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.3109/09637486.2014.886184</pub-id>
<?supplied-pmid 24548119?><pub-id pub-id-type="pmid">24548119</pub-id></element-citation></ref><ref id="B30-ijms-18-00141"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ado</surname><given-names>M.A.</given-names></name><name><surname>Abas</surname><given-names>F.</given-names></name><name><surname>Mohammed</surname><given-names>A.S.</given-names></name><name><surname>Ghazali</surname><given-names>H.M.</given-names></name></person-group>
<article-title>Anti- and pro-lipase activity of selected medicinal, herbal and aquatic plants, and structure elucidation of an anti-lipase compound</article-title>
<source>Molecules</source>
<year>2013</year>
<volume>18</volume>
<fpage>14651</fpage>
<lpage>14669</lpage>
<pub-id pub-id-type="doi">10.3390/molecules181214651</pub-id>
<?supplied-pmid 24287996?><pub-id pub-id-type="pmid">24287996</pub-id></element-citation></ref><ref id="B31-ijms-18-00141"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ko</surname><given-names>E.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>K.N.</given-names></name><name><surname>Bae</surname><given-names>I.H.</given-names></name><name><surname>Sung</surname><given-names>Y.K.</given-names></name><name><surname>Lee</surname><given-names>T.R.</given-names></name><name><surname>Shin</surname><given-names>D.W.</given-names></name><name><surname>Bae</surname><given-names>Y.S.</given-names></name></person-group>
<article-title>Testosterone stimulates Duox1 activity through GPRC6A in skin keratinocytes</article-title>
<source>J. Biol. Chem.</source>
<year>2014</year>
<volume>289</volume>
<fpage>28835</fpage>
<lpage>28845</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.583450</pub-id>
<?supplied-pmid 25164816?><pub-id pub-id-type="pmid">25164816</pub-id></element-citation></ref><ref id="B32-ijms-18-00141"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Squaiella-Baptist&#x000e3;o</surname><given-names>C.C.</given-names></name><name><surname>Teixeira</surname><given-names>D.</given-names></name><name><surname>Mussalem</surname><given-names>J.S.</given-names></name><name><surname>Ishimura</surname><given-names>M.E.</given-names></name><name><surname>Longo-Maug&#x000e9;ri</surname><given-names>I.M.</given-names></name></person-group>
<article-title>Modulation of Th1/Th2 immune responses by killed <italic>Propionibacterium acnes</italic> and its soluble polysaccharide fraction in a type I hypersensitivity murine model: Induction of different activation status of antigen-presenting cells</article-title>
<source>J. Immunol. Res.</source>
<year>2015</year>
<volume>132083</volume>
<pub-id pub-id-type="doi">10.1155/2015/132083.</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig id="ijms-18-00141-f001" position="float"><label>Figure 1</label><caption><p>Anti-ear edema effects of pomegranate extract (PG-E) ointment against a <italic>P</italic>. <italic>acnes</italic> injection; * <italic>p</italic> &#x0003c; 0.05, compared to the vehicle group on the same day; Data are presented as the mean &#x000b1; SD; Significance was calculated using Student&#x02019;s <italic>t</italic>-test by SPSS software v.15; Each group contained eight rats.</p></caption><graphic xlink:href="ijms-18-00141-g001"/></fig><fig id="ijms-18-00141-f002" position="float"><label>Figure 2</label><caption><p>Shrinkage and damage of <italic>S</italic>. <italic>aureus</italic> (<bold>A</bold>) and <italic>P</italic>. <italic>acnes</italic> (<bold>B</bold>) after treatment with four hydrolysable tannins isolated from pomegranate extract (PG-E): punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>); All photos were taken with scanning electron microscopy; C: control group; The concentration of <bold>1</bold> to <bold>4</bold> was 100 &#x000b5;g/mL; Data are from three separate experiments, the picture of one of which is shown; The arrow indicates a disruption site of bacteria; Scale bar of control group is 5 &#x000b5;m; Scale bar of four hydrolysable tannins against <italic>S</italic>. <italic>aureus</italic> and <italic>P</italic>. <italic>acnes</italic> is 5 &#x000b5;m and 2 &#x000b5;m, respectively.</p></caption><graphic xlink:href="ijms-18-00141-g002"/></fig><fig id="ijms-18-00141-f003" position="float"><label>Figure 3</label><caption><p>Lipase activity inhibition of pomegranate extract (PG-E) and four hydrolysable tannins included punicalagin (<bold>1</bold>), punicalin (<bold>2</bold>), strictinin A (<bold>3</bold>), and granatin B (<bold>4</bold>); The concentration of PG-E, and Compounds <bold>1</bold>&#x02013;<bold>4</bold> was 200 &#x000b5;g/mL; Data are from three repeats.</p></caption><graphic xlink:href="ijms-18-00141-g003"/></fig><fig id="ijms-18-00141-f004" position="float"><label>Figure 4</label><caption><p>Testosterone significantly induced keratinocyte over-proliferation in a dose- and time-dependent manner.</p></caption><graphic xlink:href="ijms-18-00141-g004"/></fig><fig id="ijms-18-00141-f005" position="float"><label>Figure 5</label><caption><p>Cytotoxicity of different hydrolysable tannins (<bold>A</bold>); Anti-keratinocyte over-proliferative effects of hydrolysable tannins (<bold>B</bold>); B: blank; C: control; * <italic>p</italic> &#x0003c; 0.05, compared to the testosterone-only group; Data are presented as the mean &#x000b1; SD; Significance was calculated using a one-way analysis of variance (ANOVA) via SPSS software v.15; Data are from three repeats.</p></caption><graphic xlink:href="ijms-18-00141-g005"/></fig><fig id="ijms-18-00141-f006" position="float"><label>Figure 6</label><caption><p>Heat-killed <italic>P</italic>. <italic>acnes</italic> (HKP) dose-dependently increased nitric oxide (NO) (<bold>A</bold>) and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) (<bold>B</bold>) production by RAW 264.7 cells; Anti-inflammatory effects of hydrolysable tannins against HKP-induced NO (<bold>C</bold>) and PGE<sub>2</sub> (<bold>D</bold>) production by RAW 264.7 cells; Data are from three repeats.</p></caption><graphic xlink:href="ijms-18-00141-g006"/></fig><fig id="ijms-18-00141-f007" position="float"><label>Figure 7</label><caption><p>Anti-interleukin (IL)-8 (<bold>A</bold>) and tumor necrosis factor (TNF)-&#x003b1; (<bold>B</bold>) release from THP-1 cells after heat-killed <italic>P</italic>. <italic>acnes</italic> (HKP) induction; * <italic>p</italic> &#x0003c; 0.05, compared to the HKP-only group; Data are presented as the mean &#x000b1; SD; Significance was calculated using a one-way analysis of variance (ANOVA) by SPSS software v.15; Data are from three repeats.</p></caption><graphic xlink:href="ijms-18-00141-g007"/></fig><fig id="ijms-18-00141-f008" position="float"><label>Figure 8</label><caption><p><italic>P</italic>. <italic>acnes</italic>-induced ear edema in Wistar rats.</p></caption><graphic xlink:href="ijms-18-00141-g008"/></fig><table-wrap id="ijms-18-00141-t001" position="float"><object-id pub-id-type="pii">ijms-18-00141-t001_Table 1</object-id><label>Table 1</label><caption><p>The pathogenic mechanism of acne and experimental design of our platform.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pathogenesis of Acne Vulgaris</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Epithelial Cell &#x00026; Keratin Accumulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sebum Accumulation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial Growth</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Skin Inflammation</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro experimental designs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Testosterone-induced HaCaT cell proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-lipase activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Propionibacterium</italic>
<italic>acnes</italic><break/><italic>Staphylococcus</italic>
<italic>aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heat-killed <italic>P</italic>. <italic>acnes</italic>-induced RAW 264.7<break/>Heat-killed <italic>P</italic>. <italic>acnes</italic>-induced THP-1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effective hydrolysable tannins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punicalagin (<bold>1</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Punicalin (<bold>2</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strictinin A (<bold>3</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Granatin B (<bold>4</bold>)</td></tr></tbody></table><table-wrap-foot><fn><p><italic>P. acnes</italic>: <italic>Propionibacterium acnes.</italic></p></fn></table-wrap-foot></table-wrap><table-wrap id="ijms-18-00141-t002" position="float"><object-id pub-id-type="pii">ijms-18-00141-t002_Table 2</object-id><label>Table 2</label><caption><p>Anti-<italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> effects of pomegranate extract (PG-E).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PG-E Samples</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Diameter of Inhibition Zone (mm)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">PG-E (mg/disc)</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>P</italic>. <italic>acnes</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">11.3 &#x000b1; 0.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">15.1 &#x000b1; 0.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1.0</td><td align="center" valign="middle" rowspan="1" colspan="1">17.1 &#x000b1; 1.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PG-E (mg/disc)</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S</italic>. <italic>aureus</italic></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">12.6 &#x000b1; 0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">15.4 &#x000b1; 0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.9 &#x000b1; 0.7</td></tr></tbody></table></table-wrap><table-wrap id="ijms-18-00141-t003" position="float"><object-id pub-id-type="pii">ijms-18-00141-t003_Table 3</object-id><label>Table 3</label><caption><p>Anti-<italic>P</italic>. <italic>acnes</italic> and <italic>S</italic>. <italic>aureus</italic> effects of pomegranate extract (PG-E).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Anti-Bacterial Activity</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC/MBC (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>P</italic>. <italic>acnes</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">6.25/12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">6.25/12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5/25</td><td align="center" valign="middle" rowspan="1" colspan="1">100/-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>. <italic>aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5/25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5/25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25/50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5/25</td></tr></tbody></table><table-wrap-foot><fn><p>MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration. </p></fn></table-wrap-foot></table-wrap></floats-group></article>